Sign up for access to exclusive content, events, materials and updates from OWL.
Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!
LEARN MOREIt’s time to honor your peers who are advancing diversity in leadership.OWL is pleased to accept nominations for the 2021…
On June 18, 2021, OWL and Alcon collaborated to host a virtual program “Eyes on Inclusion.” Coinciding with Pride Month,…
Rebecca Sanford serves as the Chief People Officer where she is responsible for building and leading talent management strategies and…
Developing leaders is OWL's mission and our specialty! Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:
OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible. OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).
Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications. Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.
LEARN MOREThe OWL Awards are given annually at OWL's Signature Event during AAO. The finalists are distinguished and respected - always an impressive group!
Nominations for the OWL Awards open in the Summer. A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.
Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.
LEARN MORESenior Director of Business Development and Market Strategy
Ocuphire Pharma
Ronil Patel currently serves as Senior Director of Business Development and Market Strategy at Ocuphire Pharma. Mr. Patel has 15 years of experience in medical research, including biotech R&D, and pharmaceutical business development. He has been in ophthalmology since 2012 and has managed multiple clinical stage assets that resulted in FDA approval, and are currently being commercialized in the US. Mr. Patel’s global business development experience involves in-licensing clinical stage assets for development in the US. He has been part of several NewCos that raised over $25 million in funding and exit deals valued at over $300 million. Prior to 2012, Mr. Patel worked as a research scientist in drug discovery and delivery areas of oncology and infectious disease. Mr. Patel holds a Master of Science degree with specialization in Biotechnology from Florida Institute of Technology.
More OWL ChampionsVP Global Glaucoma
Alcon
Cari Stone is Vice President, Global Glaucoma for Alcon. Prior to joining Alcon, Ms. Stone was Executive Director at Allergan, an AbbVie company, where she led the $500 MM Spasticity and Movement Disorders franchise for BOTOX® therapeutic in the US. Prior to her role on BOTOX®, she led the Glaucoma surgical business (XEN®) and glaucoma therapeutics business (Lumigan®, Combigan®, Alphagan P®) at Allergan.
Prior to Allergan, Cari spent 7 years in Oncology at Amgen in various commercial roles including HCP and patient marketing, strategy, operations, and sales. She also spent time at Blue Cross Blue Shield Association and worked as a strategy consultant at Deloitte.
Ms. Stone holds a Bachelor’s in Finance and Accounting from Indiana University and MBA from Duke University.
More OWL Champions